EDITORIALS

Granulocyte-Macrophage Colony-Stimulating Factor: Another Cytokine With Adjuvant Therapeutic Benefit in Melanoma?

David Lawson and John M. Kirkwood

JCO Apr 1 2000: 1603–1605. [Full Text] [PDF]

RAPID PUBLICATIONS
	Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
	William A. Peters, III, P. Y. Liu, Rolland J. Barrett, II, Richard J. Stock, Bradley J. Monk, Jonathan S. Berek, Luis Souhami, Perry Grigsby, William Gordon, Jr, and David S. Alberts
	JCO Apr 1 2000: 1606–1613. [Abstract] [Full Text] [PDF]

ORIGINAL REPORTS
Melanoma
	Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor
	Lynn E. Spitler, Michael L. Grossbard, Marc S. Ernstoff, Gary Silver, Mark Jacobs, F. Ann Hayes, and Seng Jaw Soong
	JCO Apr 1 2000: 1614–1621. [Abstract] [Full Text] [PDF]

Hematologic Oncology
	Phase I Trial of Recombinant Immunotoxin Anti-Tac(Fv)-PE38 (LMB-2) in Patients With Hematologic Malignancies
	Robert J. Kreitman, Wyndham H. Wilson, Jeffrey D. White, Maryalice Stetler-Stevenson, Elaine S. Jaffe, Steven Giardina, Thomas A. Waldmann, and Ira Pastan
	JCO Apr 1 2000: 1622–1636. [Abstract] [Full Text] [PDF]

Sarcomas
	Influence of Biologic Factors and Anatomic Site in Completely Resected Liposarcoma
	David C. Linehan, Jonathan J. Lewis, Denis Leung, and Murray F. Brennan
	JCO Apr 1 2000: 1637–1643. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Chromosome Instability as an Indicator of Malignant Progression in Laryngeal Mucosa
	Joris A. Veltman, Fredrik J. Bot, Ference C. Huynen, Frans C. S. Ramaekers, Johannes J. Manni, and Anton H. N. Hopman
	JCO Apr 1 2000: 1644–1651. [Abstract] [Full Text] [PDF]
	Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer
	Everett E. Vokes, Merrill S. Kies, Daniel J. Haraf, Kerstin Stenson, Marcy List, Rod Humerickhouse, M. Eileen Dolan, Harold Pelzer, Laura Sulzen, Mary Ellyn Witt, Yi-Ching Hsieh, Bharat B. Mittal, and Ralph R. Weichselbaum
	JCO Apr 1 2000: 1652–1661. [Abstract] [Full Text] [PDF]

Lung Cancer
	Phase II Trial of Up-Front Accelerated Thoracic Radiotherapy Combined With Chemotherapy and Optional Up-Front Prophylactic Cranial Irradiation in Limited Small-Cell Lung Cancer
	A. Hügli, D. Moro, B. Mermillod, M. Bolla, P. Alberto, H. Bonnefoi, and R. Miralbell
	JCO Apr 1 2000: 1662–1667. [Abstract] [Full Text] [PDF]

Breast Cancer
	Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence
	Catherine C. Park, Michihide Mitsumori, Asa Nixon, Abram Recht, James Connolly, Rebecca Gelman, Barbara Silver, Stella Hetelekidis, Anthony Abner, Jay R. Harris, and Stuart J. Schnitt
	JCO Apr 1 2000: 1668–1675. [Abstract] [Full Text] [PDF]
	Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
	Ian C. Smith, Andrew E. Welch, Andrew W. Hutcheon, Iain D. Miller, Simon Payne, Felice Chilcott, Smruti Waikar, Teena Whitaker, Antoinne K. Ah-See, Oleg Eremin, Steven D. Heys, Fiona J. Gilbert, and Peter F. Sharp
	JCO Apr 1 2000: 1676–1688. [Abstract] [Full Text] [PDF]
	Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
	M. Schelling, N. Avril, J. Nährig, W. Kuhn, W. Römer, D. Sattler, M. Werner, J. Dose, F. Jänicke, H. Graeff, and M. Schwaiger
	JCO Apr 1 2000: 1689–1695. [Abstract] [Full Text] [PDF]
	Role of Isolated Locoregional Recurrence of Breast Cancer: Results of Four Prospective Studies
	Claudia Schmoor, Willi Sauerbrei, Gunter Bastert, and Martin Schumacher
	JCO Apr 1 2000: 1696–1708. [Abstract] [Full Text] [PDF]
	What Threshold for Adjuvant Therapy in Older Breast Cancer Patients?
	Martine Extermann, Lodovico Balducci, and Gary H. Lyman
	JCO Apr 1 2000: 1709–1717. [Abstract] [Full Text] [PDF]
	Economic Impact of Harmonizing Medical Practices: Compliance With Clinical Practice Guidelines in the Follow-Up of Breast Cancer in a French Comprehensive Cancer Center
	Dominique Mille, Thomas Roy, Marie-Odile Carrère, Isabelle Ray, Nora Ferdjaoui, Hans-Martin Späth, Franck Chauvin, and Thierry Philip
	JCO Apr 1 2000: 1718–1724. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
	M. T. Meinardi, J. A. Gietema, W. T. A. van der Graaf, D. J. van Veldhuisen, M. A. Runne, W. J. Sluiter, E. G. E. de Vries, P. B. H. Willemse, N. H. Mulder, M. P. van den Berg, H. Schraffordt Koops, and D. Th. Sleijfer
	JCO Apr 1 2000: 1725–1732. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials
	Gordon J. S. Rustin, Ann E. Nelstrop, Søren M. Bentzen, Simon J. Bond, and Patrick McClean
	JCO Apr 1 2000: 1733–1739. [Abstract] [Full Text] [PDF]
	Randomized Trial of Neoadjuvant Cisplatin, Vincristine, Bleomycin, and Radical Hysterectomy Versus Radiation Therapy for Bulky Stage IB and IIA Cervical Cancer
	Ting-Chang Chang, Chyong-Huey Lai, Ji-Hong Hong, Suei Hsueh, Kuan-Gen Huang, Hung-Hsueh Chou, Chih-Jen Tseng, Chien-Sheng Tsai, Joseph T. Chang, Cheng-Tao Lin, Huei-Hsin Chang, Pei-Jung Chao, Koon-Kwan Ng, Simon Guo-Jeng Tang, and Yung-Kwei Soong
	JCO Apr 1 2000: 1740–1747. [Abstract] [Full Text] [PDF]

Clinical Pharmacology and Pharmacokinetics
	Phase I and Pharmacologic Study of Sequences of Gemcitabine and the Multitargeted Antifolate Agent in Patients With Advanced Solid Tumors
	Alex A. Adjei, Charles Erlichman, Jeff A. Sloan, Joel M. Reid, Henry C. Pitot, Richard M. Goldberg, Prema Peethambaram, Pamela Atherton, Lorelei J. Hanson, Steven R. Alberts, and James Jett
	JCO Apr 1 2000: 1748–1757. [Abstract] [Full Text] [PDF]

Supportive Care
	Allopurinol: Intravenous Use for Prevention and Treatment of Hyperuricemia
	Richard V. Smalley, Al Guaspari, Sandra Haase-Statz, Susan A. Anderson, Donna Cederberg, and John A. Hohneker
	JCO Apr 1 2000: 1758–1763. [Abstract] [Full Text] [PDF]

Cancer Treatment-Related Issues
	Growth Factor Usage Patterns and Outcomes in the Community Setting: Collection Through a Practice-Based Computerized Clinical Information System
	Grant Swanson, Kim Bergstrom, Eva Stump, Tammi Miyahara, and E. T. Herfindal
	JCO Apr 1 2000: 1764–1770. [Abstract] [Full Text] [PDF]

Oncology Issues
	Pathology Data in the Central Databases of Multicenter Randomized Trials Need to Be Based on Pathology Reports and Controlled by Trained Quality Managers
	I. D. Nagtegaal, E. Klein Kranenbarg, J. Hermans, C. J. H. van de Velde, and J. H. J. M. van Krieken
	JCO Apr 1 2000: 1771–1779. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Drug Interactions in Palliative Care
	Stephen A. Bernard and Eduardo Bruera
	JCO Apr 1 2000: 1780–1799. [Abstract] [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Misconceptions With Staging of Soft Tissue Sarcoma

Andrew Spillane, J. Meirion Thomas, Peter W. T. Pisters, Raphael E. Pollock, Shreyaskumar R. Patel, and Robert S. Benjamin

JCO Apr 1 2000: 1800–1801. [Full Text] [PDF]

Standards of Reporting Quality of Life in Clinical Trials

Richard Stephens and Penelope Hopwood

JCO Apr 1 2000: 1801–1802. [Full Text] [PDF]

Quality of Life in Non-Small-Cell Lung Cancer

Luke Hughes-Davies, Lucinda Billingham, and Michael Cullen

JCO Apr 1 2000: 1802. [Full Text] [PDF]

Letrozole: Which Dose to Be Used?

Aman U. Buzdar, H. A. Chaudri, and Patrick F. Trunet

JCO Apr 1 2000: 1802-a–1803. [Full Text] [PDF]

Maintenance Chemotherapy in Advanced Ovarian Cancer

M. Steven Piver, Franco M. Muggia, Mark F. Brady, and Ronald Alvarez

JCO Apr 1 2000: 1803–1805. [Full Text] [PDF]

Plasma MMPs as Surrogates of Bay 12-9566

Stanley Zucker, S. Gail Eckhardt, and Eric K. Rowinsky

JCO Apr 1 2000: 1805–1806. [Full Text] [PDF]

Hepatic Arterial Chemotherapy: Still on Trial

D. J. Kerr and R. J. Midgley C. S. McArdle

JCO Apr 1 2000: 1806–1807. [Full Text] [PDF]

Is Tamoxifen Cost-Effective for Prevention of Breast Cancer?

John Duelge and Thomas J. Smith Bruce E. Hillner

JCO Apr 1 2000: 1807. [Full Text] [PDF]

Scott D. Young

JCO Apr 1 2000: 1808. [Full Text] [PDF]

Errata

Erratum

JCO Apr 1 2000: 1807-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.